Quantum Xchange Releases Virtual Container Key Management Solution for Post-Quantum Cryptography

PHIO Stock  USD 2.53  0.21  7.66%   
About 62% of all Phio Pharmaceuticals' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Phio Pharmaceuticals Corp suggests that some traders are interested. Phio Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Phio Pharmaceuticals Corp. Many technical investors use Phio Pharmaceuticals Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
SAN DIEGO, June 12, 2025--Today at Cisco Live, Ciscos annual IT and communications conference, Quantum Xchange announced that its Post-Quantum Cryptography key management solution, Phio TX, is now available as a virtual container. The new form factor, Phio TX-EM, is compatible with Cisco networking operating systems IOS XE, IOS XR, as well as the Nexus NX-OS operating system, which will allow Cisco networking users to harden their infrastructure and easily migrate to NIST-standard PQC wi

Read at finance.yahoo.com
Yahoo News
  

Phio Pharmaceuticals Corp Current Investor Sentiment

Comfort Level 62

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Phio Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Phio Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Phio Pharmaceuticals Fundamental Analysis

We analyze Phio Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phio Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phio Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Phio Pharmaceuticals is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Phio Pharmaceuticals Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Phio Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Phio Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Phio Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Phio Pharmaceuticals Related Equities

PSTVPlus Therapeutics   9.43   
0%
100.0%
PALIPalisade Bio   6.90   
0%
73.0%
HOTHHoth Therapeutics   2.34   
0%
24.0%
SONNSonnet Biotherapeutics   1.50   
0%
15.0%
XBIOXenetic Biosciences   1.11   
0%
11.0%
IMMXImmix Biopharma   0.37   
0%
3.0%
ZURAZura Bio   1.22   
12.0%
0%
ENVBEnveric Biosciences   3.82   
40.0%
0%
SNOASonoma Pharmaceuticals   4.09   
43.0%
0%
When determining whether Phio Pharmaceuticals Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phio Pharmaceuticals Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phio Pharmaceuticals Corp Stock:
Check out Phio Pharmaceuticals Hype Analysis, Phio Pharmaceuticals Correlation and Phio Pharmaceuticals Performance.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.02)
Return On Assets
(0.43)
Return On Equity
(0.76)
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.